문맥압 항진증과 합병증 : 식도 및 위정맥류의 예방과 치료 = Special Review in Portal Hypertension : Prevention and management of gastroesophageal varices

다국어 초록 (Multilingual Abstract)

Gastroesophageal varices are the most common lethal complication of cirrhosis that result most directly from portal hypertension. Patients with cirrhosis and gastroesophageal varices have an hepatic venous pressure gradient (HVPG) of at least 10~12 mmHg. An increased portal pressure gradient results from both an increase in resistance to portal flow and an increase in portal blood inflow. Patients whose HVPG decreased to < 12 mmHg or at least 20% from baseline levels have a lower probability of developing recurrent variceal hemorrhage. Therefore, a reduction in HVPG is most important. Nonselective β-blockers are the gold standard in the prevention of first variceal hemorrhage in pateints with medium/large varices. Endoscopic variceal ligation (EVL) has been established as an alternative to nonselective β-blockers for the prevention of initial variceal hemorrhage. The combination of vasoconstrictive pharmacological therapy and variceal ligation is the preferred approach to the management of acute variceal hemorrhage. Prophylactic antibiotic therapy is considered standard of care as adjunctive treatment of the acute bleeding episode. Both combination pharmacological therapy and EVL have been proven effective for the prevention of recurrent variceal hemorrhage. For failures of medical therapy, TIPS or surgically created shunts are excellent salvage procedures. (Korean J Med 75:6-14, 2008)

참고문헌 (Reference)

1 "정맥류 출혈의 치료 가이드라인. 2005년 대한간학회 간경 변 합병증 치료 가이드라인"

2 주현수, "위정맥류 치료에서 Histoacryl？ (N-butyl-2-cyanoacrylate) 주입술의 장기성적 보고 -10년 경험" 대한소화기학회 49 (49): 320-326, 2007

3 심찬섭, "위식도정맥류의 예방적 치료" 1999

4 조주영, "식도, 위정맥류 출혈에 있어서 내시경적 경화요법" 1997

5 백순구, "문맥압 항진증의 보조 약물치료" 33 : 218-221, 2006

6 D'Amico G, "Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators" 38 : 599-612, 2003

7 de Franchis R, "Updating consensus in portal hypertension; Report of the Baveno IV Consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension" 22 : 846-852, 2000

8 Sanyal AJ, "Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy" 111 : 138-146, 1996

9 Boyer TD, "The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension" 41 : 386-400, 2005

10 Kravetz D, "Splanchnic and systemic hemodynamics in portal hypertensive rats during hemorrhage and blood volume restitution" 90 : 1232-1240, 1986

11 Garcia-Tsao G, "Short term effects of propranolol on portal venous pressure" 6 : 101-106, 1986

12 Kim T, "Ri factors for hemorrhage from gastric fundal varices" 25 : 307-312, 1997

13 Bhathal PS, "Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators" 1 : 325-337+, 1985

14 Abraczinkas DR, "Propranolol for the prevention of first variceal hemorrhage : A lifetime commitment?" 34 : 1096-1102, 2001

15 Gracia-Pagan JC, "Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study" 114 : 869-973, 1991

16 Moitinho E, "Prognostic value of early measurements of portal pressuer in acute variceal bleeding" 117 : 626-631, 1999

17 Bosch J, "Prevention of variceal rebleeding" 361 : 952-954, 2003

18 "Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis" 46 : 922-938, 2007

19 Sarin SK, "Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients" 16 : 1343-1349, 1992

20 Garcia-Tsao G, "Predictive models in portal hypertension, in : Portal hypertension IV. Proceeding of the Fourth Baveno International Consensus Workshop on Methology of diagnosis and treatment" Blackwell 47-100, 2006

21 The North Italian Endoscopic Club for th, "Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study" 319 : 923-989, 1988

22 Garcia-Taso G, "Portal pressure, presence of gastroesophageal varices and variceal bleeding" 5 : 419-424, 1985

23 Lebrec D, "Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis" 79 : 1139-1144, 1980

24 Pagliaro L, "Portal hypertension in cirrhosis: Natural history, in : Portal hypertension. Pathophysiology and treatment" Blackwell Scientific 72-92, 1994

25 Grace ND, "Portal hypertension and variceal bleeding: an AASLD single topic synposium" 28 : 868-880, 1998

26 Groszmann RJ, "Portal Hypertension Collaborative Group. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis" 353 : 2254-2261, 2005

27 Turnes J, "Pharmacological reduction of portal pressure and long term risk of first variceal bleeding in patients with cirrhosis" 101 : 506-512, 2006

28 Fernandez J, "Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage" 131 : 1049-1056, 2006

29 D'Amico G, "Noninvasive markers of esophageal varix: another round, not the last" 39 : 30-34, 2004

30 Groszmann RJ, "Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension" 2 : 757-762, 1982

31 Wiest R, "Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance" 19 : 411-426, 2000

32 De la Pena J, "Martin-Lorente JL, Garcia Suárez C. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial" 41 : 572-578, 2005

33 Monescillo A, "Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding" 40 : 793-801, 2004

34 Merli M, "Incidence and natural history of small esophageal varices in cirrhoitc patients" 38 : 266-272, 2003

35 El-Serag HB, "Improved survival after variceal hemorrhoage over an 11-year period in the Department of Veterans Affairs" 95 : 3566-3573, 2000

36 Carbonell N, "Improved survival after variceal bleeding in patients with cirrhosis over the past two decades" 40 : 652-659, 2004

37 Abraldes JG, "Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis" 37 : 902-908, 2003

38 Groszmann RJ, "Hemodynamic events in a prospective randomized trial of propranolol vs placebo in the prevention of the first variceal hemorrhage" 99 : 1401-1407, 1990

39 Blei AT, "Hemodynamic evaluation of isosorbide dinitrate in alcoholic cirrhosis: Pharmacokinetic-hemodynamic interactions" 93 : 576-583, 1987

40 de Franchis R, "Evolving Consensus in Portal Hypertension Report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertension" 43 : 167-176, 2005

41 Gupta TK, "Endothelial dysfunction in the intrahepatic microcirculation of the cirrhotic rat" 28 : 926-931, 1998

42 Lo GH, "Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial" 32 : 461-465, 2000

43 Spiegel BM, "Endoscopic screening for esophageal varices in cirrhosis: Is it ever cost effective?" 37 : 366-377, 2003

44 D'Amico G, "Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis" 124 : 1277-1291, 2003

45 Castaneda B, "Effects of blood volume restitution following a portal hypertensiverelated bleeding in anesthetized cirrhotic rats" 33 : 821-825, 2001

46 Rimola A, "Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document" 32 : 142-153, 2000

47 D'Amico G, "Diagnosis of portal hypertension: how and when, in : Portal Hypertension III. Proceedings of the Third Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies" Blackwell Science 36-64, 2001

48 de Franchis, "Definitions, methodology and therapeutic stragies in portal hypertension. A consensus development workshop" 15 : 256-261, 1992

49 Bolognesi M, "Complications in the medical treatment of portal hypertension. Portal hypertension III. Proceedings of the Third Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic strategies" Blackwell 180-203, 2001

50 Casado M, "Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings" 114 : 1296-1303, 1998

51 Sarin SK, "A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices" 97 : 1010-1015, 2002

52 Lo GH, "A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices" 33 : 1060-1064, 2001

53 Rengstorff DS, "A pilot study of 2-octyl cyanoacrylate injection for treatment of gastric fundal varices in humans" 59 : 553-558, 2004